📰 ET Markets 🟢 BULLISH 🕒 23 Oct 2026, 11:43 AM IST

Infinx plans $300 million IPO in India, appoints three bankers

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: Infinx plans $300 million IPO in India, appoints three bankers

📊

Market & Financial Impact: Infinx Technology Solutions has appointed Kotak Mahindra Capital, Nomura and Avendus to manage its proposed $300 million IPO, targeting FY28. Backed by KKR and Norwest Venture Partners, the healthcare IT firm provides AI-powered revenue cycle management services and has expanded through strategic investments and acquisitions, including i3 Verticals’ healthcare business.

💡

Actionable Insight: 🟢 Bullish Trigger: Positive business expansion or earnings beat may attract institutional and retail buying.

Infinx joins healthcare peers ASG Hospital, Eclat Health Solutions, Knack RCM and AGS Health, which are also reportedly planning share sales.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

KYB and KYC: Business behind the wealth creator called “Divi’s Lab” – Part 1

One company, 2 words. Bond yield and CDS: Will they decide the fate of global markets?

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

⚡

Get Breaking Stock Alerts & Q-Results on Telegram

Real-time 1200x675 image cards and financial filings delivered instantly.

Join @Zerolive_news ↗

Infinx plans $300 million IPO in India, appoints three bankers

🔥 More Live Market Stories

[CSBBANK] Investor Presentation - CSB Bank Limited

Bring the gold home. Build the market at home

Ola Electric shares plunge to six-month low after Goldman Sachs gives ‘sell’ call, downgrades target price

Raymond James downgrades First Industrial Realty stock rating on weaker outlook

Piper Sandler cuts Globe Life stock rating on medical claims concerns

Raymond James downgrades Cass Information Systems stock rating on valuation